Patent Oppositions in animal or human proteins industry

Explore the competitive field of animal or human proteins where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in animal or human proteins technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the animal or human proteins industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the animal or human proteins industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 16, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 3, 2026EIP
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 2, 2026KILBURN & STRODE
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 1, 2026SANDOZ
Liquid Composition Comprising Vegf AntagonistSAMSUNG BIOEPISFeb 16, 2026KILBURN & STRODE
Liquid Composition Comprising Vegf AntagonistSAMSUNG BIOEPISFeb 13, 2026KIVIAL
Liquid Composition Comprising Vegf AntagonistSAMSUNG BIOEPISFeb 12, 2026MAIWALD
Combination Of Collagen Peptide And Whey Protein For Use In A Condition Of The Skeletal TissueROUSSELOTNov 12, 2025COMPAGNIE GERVAIS DANONE
Combination Of Collagen Peptide And Whey Protein For Use In A Condition Of The Skeletal TissueROUSSELOTNov 7, 2025FRESENIUS KABI DEUTSCHLAND
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENAug 25, 2025DRRIES
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENAug 25, 2025DRRIES

To stay ahead in the competitive animal or human proteins industry, companies are constantly innovating. Here are the top patents facing oppositions in the animal or human proteins industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 16, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Sep 3, 2025Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCARE10
Jan 5, 2022Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization LesionBAYER HEALTHCARE7
Nov 3, 2021SyringeNOVARTIS7
Aug 10, 2022Use Of A Vegf Antagonist To Treat Angiogenic Eye DisordersREGENERON PHARMACEUTICALS5
Oct 26, 2022Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSSIFI MAB5
Sep 14, 2022Liquid Enteral Nutritional Composition With A Low Monovalent Metal Ion ContentNUTRICIA5
Feb 16, 2022SyringeNOVARTIS4
Apr 19, 2023Method For Producing Fusion Protein Having Igg Fc DomainALTEOGEN4
Apr 22, 2020Improved Methods For Manufacturing Adoptive Cell TherapiesBLUEBIRD BIO4
Nov 21, 2018Antibodies And Vaccines For Use In Therapeutic And Diagnostic Methods For Alpha-Synuclein-Related DisordersBIOARCTIC NEUROSCIENCE3